TEVA Trading Analysis - 09/16/2026 03:36 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for TEVA include:

• Teva Pharmaceutical Industries Ltd. (TEVA) announced a settlement with the US Department of Justice regarding allegations of misbranding and off-label promotion of certain medications.
• TEVA reported strong quarterly earnings, beating analyst expectations and citing increased sales of its key medications.
• The company announced a partnership with a leading research institution to develop new treatments for a range of diseases.

These headlines suggest that TEVA is actively addressing regulatory concerns, delivering strong financial performance, and investing in research and development.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $14,104,000,000
• Trailing EPS: $0.60
• Trailing P/E: 65.42
• Price-to-Book: 11.77
• Debt-to-Equity: 4.14
• Return on Equity (ROE): 9.14%
• Gross Margin: 64.41%
• Operating Margin: 11.36%
• Profit Margin: 5.03%

TEVA has a high P/E ratio, suggesting potential overvaluation. The debt-to-equity ratio is also high, which could be a concern. However, the company has a strong ROE and healthy margins.

Current Market Position:

Current price: $38.64

Recent price action: The stock has shown an upward trend, with a 50-day SMA of $35.12 and a 20-day SMA of $37.25.

Intraday momentum: The minute bars show a stable trend with a slight increase in price.

Technical Analysis:

SMA trends:

• 5-day SMA: $38.01
• 20-day SMA: $37.25
• 50-day SMA: $35.12

RSI (14): 54.03, indicating neutral momentum.

MACD: 0.73 (above signal line), suggesting a bullish trend.

Bollinger Bands: The stock price is near the upper band, indicating potential overbought conditions.

30-day high/low: $39.52 (high) and $33.89 (low), with the current price near the upper range.

True Sentiment Analysis (Delta 40-60 Options):

Overall sentiment: Bullish

Call vs Put dollar volume: 99.5% call volume, indicating strong bullish conviction.

Pure directional positioning suggests near-term expectations are bullish.

Key Price Levels:

Support: $35.00, $36.00

Resistance: $39.00, $40.00

Entry: $37.50

Target: $40.00

Stop Loss: $35.50

25-Day Price Forecast:

TEVA is projected for $39.50 to $42.00 in 25 days, based on current technical trends, momentum, and indicators.

The forecast considers the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast, recommended strategies include:

• Bull Call Spread: Buy TEVA 261009C00038000 (1.66) and sell TEVA 261009C00040000 (0.62), with a net debit of 1.04 and max profit of 0.96.
• Iron Condor: Sell TEVA 261009C00039000 (1.29) and buy TEVA 261009P00039000 (1.41), with a net credit of 0.12 and max profit of 0.12.

Risk Factors:

Technical warning signs:

• Potential overbought conditions near the upper Bollinger Band.

Sentiment divergences:

• None noted.

Volatility and ATR considerations:

• ATR (14): 1.22, indicating moderate volatility.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: TEVA shows bullish momentum with strong institutional buying.